Staged pathology in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 20, Issue SUPPL.1, 2014, Pages

  Alafuzoff, Irina ^a,b   Parkkinen, Laura ^c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Synuclein; Neuropathology; Staging

Indexed keywords

ALPHA SYNUCLEIN;

ARTICLE; BRAIN REGION; CELL COMPARTMENTALIZATION; DISEASE SEVERITY; DOPAMINERGIC NERVE CELL; HUMAN; LEWY BODY; NEOCORTEX; NERVE CELL NECROSIS; NEUROANATOMY; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHY DRAGER SYNDROME;

NEUROPATHOLOGY; STAGING; Α-SYNUCLEIN;

ALPHA-SYNUCLEIN; DISEASE PROGRESSION; HUMANS; LEWY BODIES; PARKINSON DISEASE;

EID: 84887934330     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/S1353-8020(13)70016-6     Document Type: Article

References (31)

1. Lewy PH Paralysis agitans I: Pathologische Anatomie. Handbuch der Neurologie III 1912, 920-933. Springer, Berlin.
2. Redlich E Ueber das Vorkommen von sogenannten "Amyloidkörperchen" in den Gaglienzellen der Substantia nigra beim metenzephalitischen Parkinsonismus. Monatsschr Psychiatr Neurol 1930, 75:129-137.
3. Okazaki H, Lipkin LE, Aronson SM Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol 1961, 20:237-244.
4. Kosaka K, Oyanagi S, Matsushita M, Hori A Presenile dementia with Alzheimer-, Pick- and Lewy-body changes. Acta Neuropathol 1976, 36:221-233.
5. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M Alpha-synuclein in Lewy bodies. Nature 1997, 388:839-840.
6. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
7. Arima K, Ueda K, Sunohara N, Arakawa K, Hirai S, Nakamura M, et al. NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol 1998, 96:439-444.
8. Braak H, de Vos RA, Bohl J, Del Tredici K Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 2006, 396(1):67-72.
9. Braak H, Sastre M, Bohl JR, de Vos RA, Del Tredici K Parkinson's disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 2007, 113(4):421-429.
10. Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White CL, Arizona Parkinson's Disease Consortium, et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 2010, 119:689-702.
11. Kosaka K, Yoshimura M, Ikeda K, Budka H Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree - a new disease?. Clin Neuropathol 1984, 3:185-192.
12. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996, 47(5):1113-1124.
13. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211.
14. Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 2008, 14:501-503.
15. Parkkinen L, Pirttila T, Alafuzoff I Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance. Acta Neuropathol 2008, 115:399-407.
16. Zaccai J, Brayne C, McKeith I, Matthews F, Ince PG, MRC Cognitive Function, Ageing Neuropathology Study Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort. Neurology 2008, 70:1042-1048.
17. Lee HJ, Suk JE, Patrick C, Bae EJ, Cho JH, Rho S, et al. Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem 2010, 285(12):9262-9272.
18. Greffard S, Verny M, Bonnet AM, Seilhean D, Hauw JJ, Duyckaerts C A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death. Neurobiol Aging 2010, 31:99-103.
19. Parkkinen L, O'Sullivan S, Collins C, Petrie A, Holton JL, Revesz T, et al. Disentangling the relationship between Lewy bodies and nigral neuronal loss in Parkinson's disease. J Parkinsons Dis 2011, 4:277-286.
20. Alafuzoff I, Parkkinen L, Al-Sarraj S, Arzberger T, Bell J, Bodi I, BrainNet Europe Consortium, et al. Assessment of alpha-synuclein pathology: a study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol 2008, 67:125-143.
21. Pikkarainen M, Martikainen P, Alafuzoff I The effect of prolonged fixation time on immunohistochemical staining of common neurodegenerative disease markers. J Neuropathol Exp Neurol 2010, 69:40-52.
22. Kovacs GG, Wagner U, Dumont B, Pikkarainen M, Osman AA, Streichenberger N, et al. An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology. Acta Neuropathol 2012, 124:37-50.
23. Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I, et al. Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol 2009, 117:635-652.
24. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Consortium on DLB, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005, 65:1863-1872.
25. Müller CM, de Vos RA, Maurage CA, Thal DR, Tolnay M, Braak H Staging of sporadic Parkinson disease-related alpha-synuclein pathology: inter- and intra-rater reliability. J Neuropathol Exp Neurol 2005, 64:623-628.
26. Leverenz JB, Hamilton R, Tsuang DW, Schantz A, Vavrek D, Larson EB, et al. Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathol 2008, 8:220-224.
27. Elobeid A, Soininen H, Alafuzoff I Hyperphosphorylated tau in young and middle-aged subjects. Acta Neuropathol 2012, 23:97-104.
28. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006, 112:389-404.
29. Alafuzoff I, Gelpi E, Al-Sarraj S, Arzberger T, Attems J, Bodi I, et al. The need to unify neuropathological assessments of vascular alterations in the ageing brain: multicentre survey by the BrainNet Europe consortium. Exp Gerontol 2012, 47:825-833.
30. Rauramaa T, Pikkarainen M, Englund E, Ince PG, Jellinger K, Paetau A, et al. TAR-DNA binding protein-43 and alterations in the hippocampus. J Neural Transm 2011, 118:683-689.
31. Brunnström H, Lindberg E, Englund E Staging of Lewy-related pathology in dementia. Clin Neuropathol 2012, 31:216-223.